|
| dbGaP Submitter Subject ID (ID2) | Coriell Sample ID | Consent | Control | Gender | Race | Age | Baseline Max AMD Severity | Final Max AMD Severity |
| AR2_0794 | ED149264 | General Research Use | No | Female | White | 77 | 8 - AREDS AMD Severity Scale Step 5 | 10 - Central GA |
| AR2_1048 | ED148644 | General Research Use | No | Male | White | 81 | 10 - Central GA | 10 - Central GA |
| AR2_1588 | ED148175 | General Research Use | No | Male | White | 77 | 11b - Neovascular AMD with end-stage disease (e.g., definite disciform scar, or photocoagulation scar), or two or more of the following five characteristics of neovascular AMD: SSR detachment, PED, subretinal/sub-RPE hemorrhage, hard exudate, or fibrous tissue | 10 - Central GA |
| AR2_1673 | ED148235 | General Research Use | No | Female | White | 75 | 8 - AREDS AMD Severity Scale Step 8 | 10 - Central GA |
| AR2_1681 | ED148292 | General Research Use | No | Male | White | 82 | 10 - Central GA | 10 - Central GA |
| AR2_1867 | ED148911 | General Research Use | No | Male | White | 71 | 9 - AREDS AMD Severity Scale Step 9 | 10 - Central GA |
| AR2_2752 | ED149155 | General Research Use | No | Male | White | 67 | 9 - AREDS AMD Severity Scale Step 9 | 10 - Central GA |
| AR2_2987 | ED149556 | General Research Use | No | Male | White | 79 | 10 - Central GA | 10 - Central GA |
| AR2_3003 | ED148277 | General Research Use | No | Female | White | 80 | 10 - Central GA | 10 - Central GA |
| AR2_3239 | ED149803 | General Research Use | No | Female | White | 65 | 5 - AREDS AMD Severity Scale Step 5 | 10 - Central GA |
| AR2_4001 | ED149154 | General Research Use | No | Female | White | 61 | 9 - AREDS AMD Severity Scale Step 9 | 10 - Central GA |
| AR2_4017 | ED149073 | General Research Use | No | Male | White | 78 | 8 - AREDS AMD Severity Scale Step 8 | 10 - Central GA |
| AR2_4062 | ED149804 | General Research Use | No | Female | White | 79 | 7 - AREDS AMD Severity Scale Step 7 | 10 - Central GA |
| AR2_0616 | ED148973 | General Research Use | No | Female | White | 77 | 11a - Neovascular AMD with definite presence of one of the following five characteristics of neovascular AMD: SSR detachment, PED, subretinal/sub-RPE hemorrhage, hard exudate, or fibrous tissue | 10 - Central GA |
| AR2_0711 | ED149421 | General Research Use | No | Female | White | 80 | 7 - AREDS AMD Severity Scale Step 7 | 10 - Central GA |
| AR2_1584 | ED148760 | General Research Use | No | Female | White | 59 | 7 - AREDS AMD Severity Scale Step 7 | 10 - Central GA |
| AR2_2151 | ED149051 | General Research Use | No | Male | White | 78 | 7 - AREDS AMD Severity Scale Step 7 | 10 - Central GA |
| AR2_2486 | ED149187 | General Research Use | No | Female | White | 76 | 7 - AREDS AMD Severity Scale Step 7 | 10 - Central GA |
| AR2_2596 | ED148271 | General Research Use | No | Male | White | 62 | 9 - AREDS AMD Severity Scale Step 7 | 10 - Central GA |
| AR2_2690 | ED148541 | General Research Use | No | Female | White | 65 | 9 - AREDS AMD Severity Scale Step 9 | 10 - Central GA |